Metabolic bone disease in long-term HPN in adults

Home Parenteral Nutrition

Volumn , Issue , 2006, Pages 159-174

  Pironi, Loris ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 55849095989     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (45)

1. Advenier, E., Landry C., Colomb,V., Prandeau, D., Florent, M., Goulet, O., Ricour, C. and Corriol, O. (2003) Aluminium contamination of parenteral nutrition and aluminium loading in children on long-term parenteral nutrition. Journal of Paediatric Gastroenterology and Nutrition 36, 448-453.
2. Berkelhammer, C., Wood, R.J. and Sitrin, M. (1998) Inorganic phosphorus reduces hypercalciuria during total parenteral nutrition by enhancing renal tubular calcium absorption. Journal of Parenteral and Enteral Nutrition 22, 142-146.
3. Bjarnason, I., Macpherson, A., Mackintosh, C., Buxton-Thomas, M., Forgacs, I. and Moniz, C. (1997) Reduced bone density in patients with inflammatory bowel disease. Gut 40, 228-233.
4. Buchman, A.L. and Moukarzel, A. (2000) Metabolic bone disease associated with total parenteral nutrition. Clinical Nutrition 19, 217-231.
5. Calvo, M.S., Eyre, D.R. and Gundemberg, C.M. (1996) Molecular basis and clinical application of biological markers of bone turnover. Endocrine Reviews 17, 333-368.
6. Cohen-Solal, M., Baudoin, C., Joly, F., Vahedi, K., D'Aoust, L., De Vernejoul, M.C. and Messing, B. (2003) Osteoporosis in patients on long-term home parenteral nutrition: a longitudinal study. Journal of Bone and Mineral Research 18, 1989-1994.
7. De Vernejoul, M.C., Messing, B., Modrowski, D. et al. (1985) Multifactorial low remodelling bone disease during cyclic total parenteral nutrition. Journal of Clinical and Endocrinology Metabolism 60, 109-113.
8. Foldes, J., Rimon, B., Muggia-Sullam, M., Gimmon, Z., Leitcher, I., Steinberg, R., Menczel, J. and Freund, H.R. (1990) Progressive bone loss during long-term home total parenteral nutrition. Journal of Parenteral and Enteral Nutrition 14, 139-142.
9. Goodman, W.G., Misra, S., Veldhuis, J.D. et al. (2000) Altered diurnal regulation of blood ionized calcium and serum parathyroid hormone concentrations during parenteral nutrition. American Journal of Clinical Nutrition 71, 560-568.
10. Haderslev, K.V., Jeppesen, P.B., Hartmann, B., Thulesen, J., Sorensen, H.A., Graff, J., Hansen, B.S., Tofteng, F., Poulsen, S.S., Madsen, J.L., Holst, J.J., Staun, M. and Mortensen, P.B. (2002a) Short-term administration of glucagon-like peptide-2. Effects on bone mineral density and markers of bone turnover in short-bowel patients with no colon. Scandinavian Journal of Gastroenterology 37, 392-398.
11. Haderslev, K.V., Tjellesen, L., Sorensen, H.A. and Staun, M. (2002b) Effect of cyclical intravenous clodronate therapy on bone mineral density and markers of bone turnover in patients receiving home parenteral nutrition. American Journal of Clinical Nutrition 76, 482-488.
12. Haderslev, K.V., Jeppesen, P.B., Sorensen, H.A., Mortensen, P.B. and Staun, M. (2003) Vitamin D status and measurements of markers of bone metabolism in patients with small intestinal resection. Gut 52, 653-658.
13. Haderslev, K.V., Tjellesen, L., Haderslev, P.H. and Staun, M. (2004) Assessment of the longitudinal changes in bone mineral density in patients receiving home parenteral nutrition. Journal of Parenteral and Enteral Nutrition 28, 289-294.
14. Jeejeebhoy, K.N. (1998) Metabolic bone disease and total parenteral nutrition: a progress report. American Journal of Clinical Nutrition 67, 186-187.
15. Kanis, J.A. (2002) Diagnosis of osteoporosis and assessment of fracture risk. Lancet 359, 1929-1936.
16. Klein, G.L. (1995) Aluminum in parenteral solutions revisited-again. American Journal of Clinical Nutrition 61, 449-456.
17. Klein, G.L. and Coburn, J.W. (1991) Parenteral nutrition: effect on bone and mineral homeostasis. Annual Review of Nutrition 11, 93-119.
18. Klein, G.L., Ament, M.E., Bluestone, R. et al. (1980) Bone disease associated with total parenteral nutrition. Lancet ii, 1041-1044.
19. Klein, G.L., Alfrey, A.C., Shike, M. et al. (1991) Parenteral drug products containing aluminum as an ingredient or a contaminant: response to FDA notice of intent. American Journal of Clinical Nutrition 53, 399-402.
20. Koo, W.W.K. (1992) Parenteral nutritionrelated bone disease. Journal of Parenteral and Enteral Nutrition 16, 386-394.
21. Ling, P.R., Khaodhiar, L., Bistrian, B., Keane-Ellison, M., Thibault, A. and Tawa, N. (2001) Inflammatory mediators in patients receiving long-term home parenteral nutrition. Digestive Disease and Science 46, 2484-2489.
22. Lipkin, E.W. (1998) A longitudinal study of calcium regulation in a nonhuman primate model of parenteral nutrition. American Journal of Clinical Nutrition 67, 246-254.
23. Lipkin, E.W., Ott, S.M. and Klein, G.L. (1987) Heterogeneity of bone histology in parenteral nutrition patients. American Journal of Clinical Nutrition 146, 673-680.
24. Lipkin, E.W., Ott, S.M., Chestnut, C.H. et al. (1988) Mineral loss in parenteral nutrition patients. American Journal of Clinical Nutrition 47, 515-523.
25. Lipkin, E.W., Ott, S.M., Klein, G.L. et al. (1990) Serum markers of bone formation in parenteral nutrition patients. Calcified Tissue International 147, 75-81.
26. Matsui, J., Cameron, R.G., Kurian, R., Kuo, G.C. and Jeejeebhoy, K.N. (1993) Nutritional, hepatic and metabolic effects of cachectin/tumour necrosis factor in rats receiving total parenteral nutrition. Gastroenterology 104, 235-243.
27. Mauras, N., George, D., Evans, J., Milov, D., Abrams, S., Rini, A., Welch, S. and Haymond, M.W. (2002) Growth hormone has anabolic effects in glucocorticosteroiddependent children with inflammatory bowel disease: a pilot study. Metabolism 51, 127-135.
28. Ogle, C.K., Zuo, L., Mao, J.X., Alexander, J.W., Fischer, J.E. and Nussbaum, M.S. (1995) Differential expression of intestinal and splenic cytokines after parenteral nutrition. Archives of Surgery 130, 1301-1307.
29. Ott, S.M., Maloney, N.A., Klein, G.L., Alfrey, C.A., Ament, M.E., Coburn, J.W. and Sherrard, D.J. (1980) Bone disease associated with total parenteral nutrition. Lancet ii, 1041-1044.
30. Pironi, L., Zolezzi, C., Ruggeri, E. et al. (2000) Bone turnover in short-term and long-term home parenteral nutrition for benign disease. Nutrition 16, 272-277.
31. Pironi, L., Labate, A.M., Pertkiewicz, M., Przedlacki, J., Tjellesen, L., Staun, M., De Francesco, A., Gallenca, P., Guglielmi, F.W., Van Gossum, A., Orlandoni, P., Contaldo, F. and Moreno Villares, J.M. (2002) Prevalence of bone disease in patients on home parenteral nutrition. Clinical Nutrition 21, 289-296.
32. Pironi, L., Paganelli, F., Labate, A.M., Merli, C., Guidetti, C., Spinucci, G. and Miglioli, M. (2003) Safety and efficacy of home parenteral nutrition for chronic intestinal failure: a 16-year experience at a single centre. Digestive and Liver Disease 5, 314-324.
33. Pironi, L., Tjellesen, L., De Francesco, A., Pertkiewicz, M., Morselli Labate, A.M., Staun, M., Przedlacki, J., Lezo, A., Orlandoni, P. and Pasanisi, F.; ESPEN-home artificial nutrition working group (2004) Bone mineral density in patients on home parenteral nutrition: a follow-up study. Clinical Nutrition 23, 1288-1302.
34. Saitta, J.C., Ott, S.M., Sherrard, D.J. et al. (1993) Metabolic bone disease in adults receiving long-term parenteral nutrition: longitudinal study with regional densitometry and bone biopsy. Journal of Parenteral and Enteral Nutrition 17, 214-219.
35. Schulte, C.M.S., Dignass, A.U., Goebell, H., Röher, H.D. and Schulte, K.M. (2000) Genetic factors determine extent of bone loss in inflammatory bowel disease. Gastroenterology 119, 909-920.
36. Seidner, D.L. and Licata, A. (2000) Parenteral nutrition-associated bone disease: pathophysiology, evaluation and treatment. Nutrition in Clinical Practice 15, 163-170.
37. Shike, M., Harrison, J.E. and Sturtridge, W.C. (1980) Metabolic bone disease in patients receiving long-term total parenteral nutrition. Annals of Internal Medicine 92, 343-350.
38. Shike, M., Sturtridge, W.C., Tam, C.S. et al. (1981) A possible role of vitamin D in genesis of parenteral nutrition-induced metabolic bone disease. Annals of Internal Medicine 95, 560-568.
39. Shike, M., Shils, M.E., Heller, A. et al. (1986) Bone disease in prolonged parenteral nutrition: osteopenia without mineralization defect. American Journal of Clinical Nutrition 44, 89-98.
40. Van Gossum, A., Vahedi, K., Abdel-Malik, Staun, M., Pertkiewicz, M., Shaffer, J., Hébuterne, X., Beau, P., Guedon, C., Schmit, A., Tjellesen, L., Messing, B., Forbes, A.; ESPEN-HAN Working Group (2001) Clinical, social and rehabilitation status of long-term home parenteral nutrition patients: results of a European multicentre survey. Clinical Nutrition 20, 205-210.
41. Vargas, J.H., Klein, G.L., Ament, M.E. et al. (1988) Metabolic bone disease of total parenteral nutrition: course after changing from casein to amino acids in parenteral solution with reduced aluminium content. American Journal of Clinical Nutrition 48, 1070-1078.
42. Verhage, A.H., Cheong, W.K., Allard, J.P. and Jeejeebhoy, K.N. (1995) Increase in lumbar spine bone mineral content in patients on long-term parenteral nutrition without vitamin D supplementation. Journal of Parenteral and Enteral Nutrition 19, 431-436.
43. Whitfield, J.F., Morley, P. and Willick, G.E. (1999) The bone-building action of the parathyroid hormone. Drugs and Aging 15, 117-129.
44. WHO (1994) Assessment of Osteoporotic Fracture Risk and its Role in Screening for Post-menopausal Osteoporosis. WHO Technical Report Series, Geneva.
45. Wood, R.J., Sitrin, M.D., Cusson, G.J. and Rosenberg, I.H. (1986) Reduction of total parenteral nutrition-induced urinary calcium loss by increasing the phosphorus in the total parenteral nutrition prescription. Journal of Parenteral and Enteral Nutrition 10, 188-190.